Healthcare Engineering Simulation
Advancing In Silico Medicine
Modeling and simulation are proven ways to address the high and unsustainable costs and time required for design and regulatory approval of increasingly complex healthcare solutions. This in silico approach maximizes patient safety while making healthcare more affordable.
Accelerating Innovation in Healthcare With In Silico Medicine
With a patient’s well-being and even life at stake, product failure is not an option. Realizing the benefits of in silico medicine by applying engineering simulation throughout development and the regulatory approval process, accelerates innovation, reduces cost and shortens time to market while meeting safety standards and product deadlines.
-
Medical Devices
-
Clinical Applications
-
Pharma/Biopharma
Medical Devices
Engineering simulation of medical devices and their interaction with the body accelerate innovation, design optimization and regulatory approval processes.
Clinical Applications
Clinically validated, predictive computer models of surgical and medical protocols applied to patient-specific models deliver improved patient outcomes.
Pharma and Biopharma
Physics based simulation optimizes drug production processes and provides scaled delivery mechanisms to the target population.
Applications
The adoption of in silico methods is pervasive across all healthcare sectors. Engineering simulation is used during discovery and ideation, invention and prototyping, pre-clinical, clinical, and regulatory decision-making.
For modern connected devices, such as wearable insulin pumps, in silico methods help designers optimize catheters, needles, embedded software and insulin absorption.
Modeling and simulation have also been adopted to optimize orthopedic and cardiovascular implants, respiratory devices, hospital equipment and drug manufacturing and delivery.
Disruption in Healthcare is Here
In silico medicine is set to drastically change the way engineers approach healthcare solutions.
In silico medicine— synonymous with “computational” medicine—is revolutionizing the equipment and procedures of the health care industry. This approach takes advantage of digital modeling and simulation. Many industry leaders have turned to Ansys software to pursue this approach as it offers fast product development cycles along with reduced costs.
The medical industry has only recently adopted simulation-based techniques. In this whitepaper you’ll see how this is pushing the boundaries of health care solutions. For example, simulation is responsible for medical innovative approaches such as Virtual Human Laboratory (VHL) which allows users to understand the effects of implants or drugs, in a digital workspace. This reduces risks associated with traditional testing and can even assist with FDA approval. It is a win-win situation that can increase safety and performance while simultaneously reducing development costs and time to market.
The Rise of In Silico Medicine
To accelerate adoption and ensure the highest safety standards are maintained, the leading medical device and pharma companies, in collaboration with the regulators and simulation industry, have developed best practices to enable dramatic cost and time to market reduction while maximizing patient safety.
Marc Horner
Contact Us
Thierry Marchal
Contact Us
Michel Rochette
Contact UsFeatured Webinars
Healthcare Webinar Series
This healthcare industry webcast series shares the knowledge and experience of Ansys experts and our partners to guide you in the strategic adoption of engineering simulation.